{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:11:59Z","timestamp":1790507519224,"version":"4.1.0"},"reference-count":72,"publisher":"BMJ","issue":"8","funder":[{"DOI":"10.13039\/100001545","name":"Children\u2019s Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,6,11]]},"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Dopamine dysregulation has been identified as a key modulator of behavioural impairment in neurofibromatosis type 1 (NF1) and a potential therapeutic target. Preclinical research demonstrates reduced dopamine in the brains of genetically engineered NF1 mouse strains is associated with reduced spatial-learning and attentional dysfunction. Methylphenidate, a stimulant medication that increases dopaminergic and noradrenergic neurotransmission, rescued the behavioural and dopamine abnormalities. Although preliminary clinical trials have demonstrated that methylphenidate is effective in treating attention deficit hyperactivity disorder (ADHD) symptoms in children with NF1, its therapeutic effect on cognitive performance is unclear. The primary aim of this clinical trial is to assess the efficacy of methylphenidate for reducing attention deficits, spatial working memory impairments and ADHD symptoms in children with NF1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A randomised, double-blind, placebo-controlled trial of methylphenidate with a two period crossover design. Thirty-six participants with NF1 aged 7\u201316 years will be randomised to one of two treatment sequences: 6 weeks of methylphenidate followed by 6 weeks of placebo or; 6 weeks of placebo followed by 6 weeks of methylphenidate. Neurocognitive and behavioural outcomes as well as neuroimaging measures will be completed at baseline and repeated at the end of each treatment condition (week 6, week 12). Primary outcome measures are omission errors on the Conners Continuous Performance Test-II (attention), between-search errors on the Spatial Working Memory task from the Cambridge Neuropsychological Test Automated Battery (spatial working memory) and the Inattentive and Hyperactivity\/Impulsivity Symptom Scales on the Conners 3-Parent. Secondary outcomes will examine the effect of methylphenidate on executive functions, attention, visuospatial skills, behaviour, fine-motor skills, language, social skills and quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This trial has hospital ethics approval and the results will be disseminated through peer-reviewed publications and international conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ACTRN12611000765921.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-021800","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T15:58:52Z","timestamp":1535644732000},"page":"e021800","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial"],"prefix":"10.1136","volume":"8","author":[{"given":"Natalie A","family":"Pride","sequence":"first","affiliation":[{"name":"Institute for Neuroscience and Muscle Research, The Children\u2019s Hospital at Westmead, Westmead, New South Wales, Australia"},{"name":"Discipline of Child and Adolescent Health, Sydney Medical School, Universtiy of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Barton","sequence":"additional","affiliation":[{"name":"Institute for Neuroscience and Muscle Research, The Children\u2019s Hospital at Westmead, Westmead, New South Wales, Australia"},{"name":"Discipline of Child and Adolescent Health, Sydney Medical School, Universtiy of Sydney, Sydney, New South Wales, Australia"},{"name":"Children\u2019s Hosptial Education Research Institute, The Children\u2019s Hospital at Westmead, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hutchins","sequence":"additional","affiliation":[{"name":"Children\u2019s Hosptial Education Research Institute, The Children\u2019s Hospital at Westmead, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Coghill","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute, The Royal Children\u2019s Hospital, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Department of Psychiatry, Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuresh S","family":"Korgaonkar","sequence":"additional","affiliation":[{"name":"Brain Dynamics Centre, Westmead Institute for Medical Research, University of Sydney, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J C","family":"Hearps","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute, The Royal Children\u2019s Hospital, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Rouel","sequence":"additional","affiliation":[{"name":"Institute for Neuroscience and Muscle Research, The Children\u2019s Hospital at Westmead, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Malarbi","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute, The Royal Children\u2019s Hospital, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn N","family":"North","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute, The Royal Children\u2019s Hospital, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9565-3845","authenticated-orcid":false,"given":"Jonathan M","family":"Payne","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute, The Royal Children\u2019s Hospital, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,8,30]]},"reference":[{"key":"2025120518521583000_8.8.e021800.1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33139"},{"key":"2025120518521583000_8.8.e021800.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00245-8"},{"key":"2025120518521583000_8.8.e021800.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2012.12.002"},{"key":"2025120518521583000_8.8.e021800.4","doi-asserted-by":"publisher","DOI":"10.1038\/356713a0"},{"key":"2025120518521583000_8.8.e021800.5","doi-asserted-by":"publisher","DOI":"10.1136\/adc.64.5.745"},{"key":"2025120518521583000_8.8.e021800.6","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000179303.72345.ce"},{"key":"2025120518521583000_8.8.e021800.7","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162206002131"},{"key":"2025120518521583000_8.8.e021800.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2012.04399.x"},{"key":"2025120518521583000_8.8.e021800.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6620-5"},{"key":"2025120518521583000_8.8.e021800.10","doi-asserted-by":"publisher","DOI":"10.1080\/09297049.2010.542746"},{"key":"2025120518521583000_8.8.e021800.11","doi-asserted-by":"publisher","DOI":"10.1177\/0883073812439435"},{"key":"2025120518521583000_8.8.e021800.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2012.04357.x"},{"key":"2025120518521583000_8.8.e021800.13","doi-asserted-by":"publisher","DOI":"10.1037\/a0013927"},{"key":"2025120518521583000_8.8.e021800.14","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162201001876"},{"key":"2025120518521583000_8.8.e021800.15","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000055090.78351.C1"},{"key":"2025120518521583000_8.8.e021800.16","doi-asserted-by":"publisher","DOI":"10.1080\/87565641.2012.695831"},{"key":"2025120518521583000_8.8.e021800.17","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291713002547"},{"key":"2025120518521583000_8.8.e021800.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2013.02.003"},{"key":"2025120518521583000_8.8.e021800.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1004829107"},{"key":"2025120518521583000_8.8.e021800.20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cortex.2017.04.022","article-title":"The neural basis of deficient response inhibition in children with neurofibromatosis type 1: Evidence from a functional MRI study","volume":"93","author":"Pride","year":"2017","journal-title":"Cortex"},{"key":"2025120518521583000_8.8.e021800.21","doi-asserted-by":"crossref","first-page":"499-508","DOI":"10.1007\/s11682-017-9717-8","article-title":"Impaired engagement of the ventral attention system in neurofibromatosis type 1","volume":"12","author":"Pride","year":"2018","journal-title":"Brain Imaging Behav"},{"key":"2025120518521583000_8.8.e021800.22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.24.14494"},{"key":"2025120518521583000_8.8.e021800.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(02)01904-2"},{"key":"2025120518521583000_8.8.e021800.24","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.9.1605"},{"key":"2025120518521583000_8.8.e021800.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.08.013"},{"key":"2025120518521583000_8.8.e021800.26","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.6.1067"},{"key":"2025120518521583000_8.8.e021800.27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1017\/S0012162204000921","article-title":"Social skills of children with neurofibromatosis type 1","volume":"46","author":"Barton","year":"2004","journal-title":"Dev Med Child Neurol"},{"key":"2025120518521583000_8.8.e021800.28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10519-010-9430-5","article-title":"Does cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1?","volume":"41","author":"Huijbregts","year":"2011","journal-title":"Behav Genet"},{"key":"2025120518521583000_8.8.e021800.29","doi-asserted-by":"publisher","DOI":"10.1038\/nature711"},{"key":"2025120518521583000_8.8.e021800.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2005.09.043"},{"key":"2025120518521583000_8.8.e021800.31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.3.287"},{"key":"2025120518521583000_8.8.e021800.32","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70227-8"},{"key":"2025120518521583000_8.8.e021800.33","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1212\/WNL.0000000000003435","article-title":"Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1","volume":"87","author":"Payne","year":"2016","journal-title":"Neurology"},{"key":"2025120518521583000_8.8.e021800.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2011.09.005"},{"key":"2025120518521583000_8.8.e021800.35","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23793"},{"key":"2025120518521583000_8.8.e021800.36","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq382"},{"key":"2025120518521583000_8.8.e021800.37","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv103"},{"key":"2025120518521583000_8.8.e021800.38","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-009-0054-3"},{"key":"2025120518521583000_8.8.e021800.39","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-006-0549-0"},{"key":"2025120518521583000_8.8.e021800.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2009.08.013"},{"key":"2025120518521583000_8.8.e021800.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2011.04.018"},{"key":"2025120518521583000_8.8.e021800.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2013.10.005"},{"key":"2025120518521583000_8.8.e021800.43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13023-014-0142-4","article-title":"The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial","volume":"9","author":"Lion-Fran\u00e7ois","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"2025120518521583000_8.8.e021800.44","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05305whi"},{"key":"2025120518521583000_8.8.e021800.45","unstructured":"Conners CK. Conners. 3rd Edition. Parent Toronto, Ontario: Multi-Health Systems Inc, 2008."},{"key":"2025120518521583000_8.8.e021800.46","unstructured":"Conners CK. Conners Continuous Performance Test II (CPT-II) Version 5.1 for Windows. Canada: Multi-Health Systems Inc, 2000."},{"key":"2025120518521583000_8.8.e021800.47","doi-asserted-by":"publisher","DOI":"10.1111\/1469-7610.00152"},{"key":"2025120518521583000_8.8.e021800.48","doi-asserted-by":"crossref","unstructured":"Wechsler D . Wechsler abbreviated scale on intelligence- second edition. San Antonio, Texas: Psychological Corporation, 2011.","DOI":"10.1037\/t15171-000"},{"key":"2025120518521583000_8.8.e021800.49","unstructured":"Wechsler D . WISC-IV Australian Administration and Scoring Manual: Harcourt Assessment, 2003."},{"key":"2025120518521583000_8.8.e021800.50","unstructured":"Wechsler D . Wechsler Intelligence Scale for Children. 5 edn. Australian and New Zealand: Standardised Edition (WISC-V A&NZ). Bloomington MN Pearson, 2016."},{"key":"2025120518521583000_8.8.e021800.51","unstructured":"Roid GH . Stanford-Binet Intelligence Scales. 5 edn: Rolling Meadows IL: Riverside Publishing, 2003."},{"key":"2025120518521583000_8.8.e021800.52","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520290115023"},{"key":"2025120518521583000_8.8.e021800.53","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-02-j0001.2001"},{"key":"2025120518521583000_8.8.e021800.54","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.3.387"},{"key":"2025120518521583000_8.8.e021800.55","doi-asserted-by":"publisher","DOI":"10.1542\/peds.100.4.662"},{"key":"2025120518521583000_8.8.e021800.56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/070674370200601S05","article-title":"Mechanism of action of methylphenidate: insights from PET imaging studies","volume":"6 Suppl 1","author":"Volkow","year":"2002","journal-title":"J Atten Disord"},{"key":"2025120518521583000_8.8.e021800.57","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-4-28","article-title":"Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data","volume":"4","author":"Sonuga-Barke","year":"2004","journal-title":"BMC Psychiatry"},{"key":"2025120518521583000_8.8.e021800.58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11689-016-9159-4","article-title":"Sex bias in autism spectrum disorder in neurofibromatosis type 1","volume":"8","author":"Garg","year":"2016","journal-title":"J Neurodev Disord"},{"key":"2025120518521583000_8.8.e021800.59","unstructured":"Conners CK . Conners' ADHD\/DSM-IV Scales: Parent version. New York: Multi-Health Systems Inc, 1999."},{"key":"2025120518521583000_8.8.e021800.60","doi-asserted-by":"publisher","DOI":"10.1080\/13803390490515757"},{"key":"2025120518521583000_8.8.e021800.61","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025457300409"},{"key":"2025120518521583000_8.8.e021800.62","unstructured":"Manly T , Robertson IH , Anderson V , et al ; The Test of Everyday Attention for Children. London: Battley Brothers, 1999."},{"key":"2025120518521583000_8.8.e021800.63","unstructured":"Instruments L . Grooved pegboard test user instructions: Lafayette Instruments Compancy Inc, 1989."},{"key":"2025120518521583000_8.8.e021800.64","doi-asserted-by":"crossref","unstructured":"Benton A , Varney N , Hamsher K . Judgment of line orientation. Iowa City: Department of Neurology, University of Iowa, 1976.","DOI":"10.1037\/t11036-000"},{"key":"2025120518521583000_8.8.e021800.65","unstructured":"Semel E , Wiig EH , Secord W . Clinical Evaluation of Language Fundamentals-Screening Test Australian & New Zealand Language Adapted Edition (CELF-4 Screener. Fourth Edition. Marrickville NSW: Harcourt Assessment, 2004."},{"key":"2025120518521583000_8.8.e021800.66","doi-asserted-by":"crossref","unstructured":"Gioia GA , Isquith PK , Steven CG , et al ; Behavior Rating Inventory of Executive Function. Florida: Psychological Assessment Resources, 2000.","DOI":"10.1037\/t73087-000"},{"key":"2025120518521583000_8.8.e021800.67","doi-asserted-by":"publisher","DOI":"10.1177\/01454455930173004"},{"key":"2025120518521583000_8.8.e021800.68","unstructured":"Achenbach TM , Rescorla LA . Manual for the ASEBA School-Age Forms and Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, and Families, 2001."},{"key":"2025120518521583000_8.8.e021800.69","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200108000-00006"},{"key":"2025120518521583000_8.8.e021800.70","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.252"},{"key":"2025120518521583000_8.8.e021800.71","unstructured":"Cohen J . Statistical Power Analysis for the Behavioural Sciences. Second Edition. Hillsdale N.J: Lawrence Erlbaum, 1988."},{"key":"2025120518521583000_8.8.e021800.72","doi-asserted-by":"crossref","unstructured":"Chow SC , Luikart BW . Design and Analysis of Bioavailability and Bioequivalence Studies. New York: Marcel Dekker, 1999.","DOI":"10.1201\/9781420002027"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-021800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T02:52:26Z","timestamp":1764989546000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-021800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":72,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,30]]},"published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1136\/bmjopen-2018-021800"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-021800","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}